MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • MDS Virtual Congress 2021

    DNMSQuest: a simple tool for identifying mood disorders in cervical dystonia?

    S. Rafee, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

    Objective: To compare DNMSQuest scores with validated measures of mood disorder in cervical dystonia patients attending a hospital botulinum toxin clinic. We wished to determine…
  • MDS Virtual Congress 2021

    Implementing Systematic Screening and a Treatment Algorithm for Depression in Parkinson’s Disease

    C. Marras, A. Naito, J. Beck, R. de Leon, A. Allen, E. Nelson, D. Weintraub, S. Luo, S. Mantri, M. Neault (Toronto, Canada)

    Objective: Assess the feasibility and impact of systematic depression screening and management in movement disorders centers. Background: Depression is common in Parkinson’s disease (PD) and…
  • MDS Virtual Congress 2021

    Impact of Restless Leg Syndrome (RLS) Severity on Cognitive Function and Depression

    K. Mangipudi, C. Adler, N. Zhang, H. Shill, S. Mehta, C. Belden, A. Atri, E. Driver-Dunckley (Scottsdale, USA)

    Objective: To determine whether cognitive dysfunction and depression are more prevalent in RLS subjects compared to controls, and if RLS severity impacts these variables. Background:…
  • MDS Virtual Congress 2021

    Depression in Patients with Parkinson’s disease among Tomsk population

    M. Nikitina, N. Alifirova, K. Nurzhanova, N. Zhukova (Tomsk, Russian Federation)

    Objective: To identify clinical predictors of depression in Tomsk PwPD. Background: Depression is often an under-recognized feature of Parkinson's disease (PD). It is important to…
  • MDS Virtual Congress 2021

    Mobile application for assessing the likelihood of developing depression in patients with Parkinson’s disease

    M. Nikitina, A. Bragin, E. Bragina, V. Alifirova, N. Zhukova, D. Gomboeva, V. Spitsyn (Tomsk, Russian Federation)

    Objective: To develop a mobile application for assessing the likelihood of developing depression in patients with Parkinson's disease (PwPD), taking into account the number of…
  • MDS Virtual Congress 2021

    Are we addressing the emotional burden? – recognition of mood disorders in patients with essential tremor

    G. Douglas, A. Doyle, S. Rafee, S. O'Riordan (Dublin, Ireland)

    Objective: To examine the assessment of non-motor symptoms in essential tremor in movement disorder clinics. Background: Essential tremor (ET) is one of the most common…
  • MDS Virtual Congress 2021

    Analysis of the correlation between the raphe nucleus echo and neurological diseases with depression/anxiety.

    YAN. Shao, YI. Liu (Dalian, China)

    Objective: The objective of this study is to assess raphe nucleus echo whether can be used as a means to distinguish endogenous and reactive depression/anxiety, so as to…
  • MDS Virtual Congress 2021

    Self perceived impact of the SARS-COV 2 pandemic on motor, non motor and affective symptoms in Parkinson’s disease and parkinsonisms.

    A. Ranghetti, V. Cereda, R. Maestri, C. Siri, M. Canesi (Gravedona Ed Uniti, Italy)

    Objective: to evaluate the perceived impact of the SARS-COV 2 pandemic on own wellbeing in people with Parkinson’s disease and parkinsonism (PWP) in Italy. Background:…
  • MDS Virtual Congress 2021

    GALLIC ACID AMELIORATES THE NEUROBEHAVIOURAL DEFICITS INDUCED BY BISPHENOL A (BPA) IN WISTAR RATS

    K. Adigun, M. Ehinmowo, A. Adebiyi, O. Adebiyi (Ibadan, Nigeria)

    Objective: Bisphenol A (BPA) has been found to exert neurotoxic effects through its neuroendocrine disruption and generation of reactive oxygen species (ROS). It can also…
  • MDS Virtual Congress 2021

    Cognitive complaints, anxiety, depression and reporting of pain in Parkinson’s Disease in a multi-ethnic population: Dissimilarities between White and Non-White patients

    K. Rukavina, L. Batzu, M. Krbot Skoric, J. Staunton, A. Sauerbier, J. Ocloo, O. Awogbemelia, D. Trived, A. Rizos, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To explore the links between cognitive complaints, anxiety and depression and reporting of pain in People with Parkinson’s disease (PD, PwP) from different ethnic…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley